Turk D C
J Hyg (Lond). 1978 Oct;81(2):227-38. doi: 10.1017/s0022172400025055.
During a 7 1/2 year period pneumococci were isolated from body fluids of 124 patients at the Radcliffe Infirmary, Oxford -72 with pneumonia, 26 with meningitis and 26 with other serious infections. Eighty-one (65%) of the patients were over 50, and 33 (27%) were over 70 years old. Of the 124 pneumococcal strains 104 (84%), including 23 (79%) of those from patients who died, belonged to types included in the vaccines successfully used in South Africa and in Papua New Guinea. The relative frequencies of types in the Oxford series and in a larger British series agreed closely with those found in a recent survey of 3644 bacteraemic pneumococcal infections in 10 American cities. Any polyvalent pneumococcal vaccine licensed for use in the United States is thus likely to be relevant to the situation in Britain.
在7年半的时间里,从牛津拉德克利夫医院124例患者的体液中分离出肺炎球菌,其中72例患有肺炎,26例患有脑膜炎,26例患有其他严重感染。81名(65%)患者年龄超过50岁,33名(27%)患者年龄超过70岁。在124株肺炎球菌菌株中,104株(84%),包括23株(79%)来自死亡患者的菌株,属于在南非和巴布亚新几内亚成功使用的疫苗所包含的类型。牛津系列和更大的英国系列中各类型的相对频率与最近对美国10个城市3644例肺炎球菌血症感染的调查结果密切一致。因此,任何在美国获得许可使用的多价肺炎球菌疫苗都可能适用于英国的情况。